Solventum Corporation SOLV

Solventum Corporation es una empresa de soluciones de atención médica. La empresa se dedica al desarrollo, fabricación y comercialización de un amplio portafolio de soluciones que aprovechan la ciencia de materiales y datos, la investigación clínica y las capacidades digitales. Solventum opera en los mercados de separación y purificación, información de salud, soluciones médicas, componentes de dispositivos médicos y cuidado bucal.

• Zacks Investment Research 5 oct

  Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names

  Zacks highlights two medical stocks with positive Earnings Surprise Prediction (ESP): CVS Health and Solventum. Both stocks have positive ESP figures and are expected to report earnings in early November 2026, suggesting potential for earnings beats based on recent analyst revisions.

  

• Zacks Investment Research 15 sept

  Why Solventum (SOLV) is a Top Stock for the Long-Term

  Zacks presents its Focus List, a curated portfolio of 50 stocks selected based on positive earnings estimate revisions. The list has historically outperformed the S&P 500, with cumulative returns of 2,519.23% since February 1996 compared to the S&P's 854.95%. The methodology relies on the Zacks Rank system, which evaluates stocks based on earnings consensus among analysts. Solventum (SOLV), a healthcare company spun off from 3M, is highlighted as a recent addition that has gained 29.89% since April 2024.

  

• Zacks Investment Research 2 sept

  Earnings Growth & Price Strength Make Solventum (SOLV) a Stock to Watch

  Solventum Corporation (SOLV), a healthcare company spun off from 3M, has been added to the Zacks Focus List. The stock has gained 31.53% since its April 2024 IPO at $69.15, now trading at $90.95. Six analysts raised earnings estimates in the last 60 days, with consensus estimates increasing $0.55 to $7.13 for fiscal 2026. The company is expected to deliver 16.7% earnings growth for the current fiscal year and has demonstrated a 13.2% average earnings surprise.

  

• GlobeNewswire Inc. 3 jul

  [Latest] Global Gauze Bandage Rolls Market Size/Share Worth USD 3.19 Billion by 2035 at a 4.97% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

  The global gauze bandage rolls market is valued at USD 1.96 billion in 2025 and is projected to reach USD 3.19 billion by 2035, growing at a CAGR of 4.97%. Growth is driven by rising surgical procedures, aging populations, chronic wound management, and technological advancements in antimicrobial and bioactive gauze products. Key market segments include cotton gauze (largest share), surgical wounds (dominant application), and hospitals (primary end-user), with Asia Pacific expected to show the fastest growth.